Severe pulmonary hemorrhage in the newborn is an infrequent, but life-threatening, event. A newborn with persistent pulmonary hypertension and a large persistent ductus arteriosus and open foramen ovale presented with hypoxemia and progressive right heart failure shortly after birth, requiring veno-arterial extracorporeal membrane oxygenation (ECMO) support. Twenty minutes after the initiation of ECMO, the patient developed severe pulmonary hemorrhage refractory to conventional treatment. As a last resort, the endotracheal tube was clamped. After transport to the ECMO center, repeated attempts to open the endotracheal tube resulted in continued blood loss and the endotracheal tube was clamped for a total of 63 hours without any mechanical ventilation. On the third postnatal day, the endotracheal tube was reopened, large amounts of clot were removed by bronchoscopy and mechanical ventilation was resumed followed by improved general condition and favorable outcome.
Introduction
Clinically apparent pulmonary hemorrhage (PH) occurs in 1 to 12 per 1000 newborns and risk factors include very low birth weight, surfactant administration and patent ductus arteriosus. [1] [2] [3] The management of PH is based on supportive therapy. Temporary clamping of the endotracheal tube has been previously reported in an adult patient with PH on extracorporeal membrane oxygenation (ECMO). 4 In this report, we describe the use of this technique of last resort in a newborn. A written consent from the parents of the patient was obtained.
Case report
A female born from a physiological pregnancy at the 40 th gestational week (weight, 2890 g; Apgar score, 9-8-7; umbilical pH, 7.37) developed hypoxemia in the 15 th minute after vaginal delivery, with SpO 2 values dropping down to 30%, which was attributed to neonatal sepsis (CRP, 86 ml/l) due to neonatal pneumonia suggested from an initial chest radiograph. The patient required endotracheal intubation, conventional mechanical ventilation, analgosedation (sufentanil and midazolam) and antibiotic treatment (gentamicin, 5 mg/kg/d; ampicillin/sulbactam, 150 mg/kg/d). Due to progressive heart failure, intravenous catecholamines Management of severe pulmonary hemorrhage in a neonate on veno-arterial ECMO by the temporary clamping of the endotracheal tube -a case report (dopamine, 10 μg/kg/min; epinephrine, 0.5 μg/kg/min) were administered. After a transfer to the regional tertiary care center, the diagnosis of persistent pulmonary hypertension and a large persistent ductus arteriosus (diameter, 5.5 mm) with a right-to-left shunt and open foramen ovale with bi-directional flow was reported. Echocardiography also showed moderate enlargement of the right ventricle and atrium with mild tricuspid valve regurgitation (Figure 1 ). Initiation of inhaled nitric oxide (iNO up to 20 ppm) and switching to highfrequency oscillatory ventilation had little effect (oxygenation index, 60; serum lactate, 7.9 mmol/l; pO 2 . Despite all attempts, the oxygenation was not improving with a pre-ductal SpO 2 of 75% and a postductal SpO 2 of 35-40%. The underlying sepsis also resulted in coagulopathy (international normalized ratio [INR] , from 1.9 to 3.8; activated partial thromboplastin time [APTT], >160 s; fibrinogen, from 1.31 to 0.54 g/l; antithrombin III, from 40% to 33%; platelet count, 219x10 9 /l to 214x10 9 /l) which was treated by vitamin K (0.6 mg i.v.) and repeated transfusions of fresh frozen plasma.
The ECMO team had been alerted and the patient was connected to veno-arterial ECMO (VA ECMO) at the remote institution at her 11 th postnatal hour. Due to coagulopathy, no anticoagulants were added prior to the introduction of ECMO cannulas to the right common carotid artery and the right internal jugular vein (Edwards 8F and Edwards 10F, respectively, Edwards Lifesciences, Unterschleißheim, Germany). A Permanent Life Support System (Maquet, Hirrlingen, Germany) and Hilite 800LT oxygenator (Medos Medizintechnik, Stolberg, Germany) were used, starting with 150 ml/min blood flow with step-wise increases to a maximum of 300 ml/min and 800 ml/min gas flow rate. The system was primed with blood and plasma without heparin. Although blood oxygenation normalized (SpO 2 , 97%) and perfusion of the body improved (mean arterial blood pressure, 50mmHg), the patient developed extensive pulmonary hemorrhage 20 minutes later, with an estimated blood loss of 120 ml/30 min. The hemorrhage was refractory to both the administration of fresh frozen plasma (140 ml and 100 ml of packed red blood cells) and changes in mechanical ventilation, with increased post end-expiratory pressure (PEEP) ( severity of the bleeding, neither an emergency bronchoscopy nor an endotracheal application of epinephrine or surfactant were feasible. 3 As a last resort, we decided to clamp the endotracheal tube (Figure 1 ) while the patient was on full ECMO support. During the 3.5-hour long transport to the ECMO center, the patient developed non-pulsatile blood flow. Bearing in mind all the consequences of this condition, including increased vascular resistance, afterload and reduced organ perfusion, we gradually decreased the ECMO flow to 220 ml/min with a gas flow rate of 800 ml/min to relieve the left ventricle and atrium while maintaining mixed venous saturation above 70%. Pulsatile blood flow restored spontaneously two hours later. Fresh frozen plasma (200 ml) and prothrombin complex concentrate (600 IU) that were repeatedly administered during the transport resulted in an improvement of coagulopathy (INR, 1.68; APTT, 57s; fibrinogen, 1.73g/l; antithrombin III, 60%; platelet count, 48x10 9 /l).
Repeated attempts to open the endotracheal tube on the first and second postnatal days resulted in ongoing blood loss. On the third postnatal day, when the coagulation was controlled (INR, 1.34; APTT maintained between 60-80s using an adjusted heparin dose from the second day, 8 IU/kg / h; fibrinogen, 2 g/l; antithrombin III, 30%; platelet count, 78x10 9 /l), the endotracheal tube was re-opened and replaced without any signs of continued hemorrhage. Large amounts of clot were removed by bronchoscopy, which was repeated three times, and mechanical ventilation finally resumed (Pin, 25 cmH 2 O; PEEP, 7 cmH 2 O; FiO 2 , 0.4).
On the third postnatal day, transthoracic echocardiography demonstrated spontaneous resolving of the ductus arteriosus and foramen ovale. Dilation of the right ventricle and atrium disappeared as well. With the improving overall condition of the patient, ECMO weaning was commenced on the 5 th day, decannulation was performed on the 7 th day and extubation on the 10 th postnatal day. The patient was transferred back to the remote tertiary perinatal facility on the 28 th day in a good condition without any signs of neurological impairment and discharged three weeks later.
Discussion
Neonatal PH is a serious condition. Its management is based on supportive therapy, mechanical ventilation with high positive end-expiratory pressure, high-frequency oscillatory ventilation, endotracheal application of epinephrine and instillation of surfactant, blood component therapy and ECMO. 2, 3, 5 However, evidence supporting these recommendations is mostly based on observational studies with a limited number of subjects.
In the present case, we considered all of the conventional therapeutic options. We were unable to perform spraying of the airways with epinephrine or application of surfactant due to continued discharge of fresh blood from the airways. 3 Facing an ongoing massive blood loss from the airways, we decided to clamp the endotracheal tube, providing gas exchange via VA ECMO. 6 A literature search provided only one previous report of endotracheal tube clamping for 36 hours in an adult patient with massive PH. 4 PH is an infrequent event during VA ECMO treatment of severe persistent pulmonary hypertension refractory to conventional treatment (inhaled nitric oxide, sildenafil, bosentan). 7 Persistent pulmonary hypertension is caused by high pulmonary vascular resistance in the presence of normal cardiac anatomy and right-to-left shunts on the foramen ovale and patent ductus arteriosus, commonly due to asphyxia, massive meconium aspiration, congenital diaphragmatic hernia or neonatal sepsis, which transpired in the present case. Because the blood cultures were negative, we did not learn the infectious agent. There was no evidence of meconium aspiration or premature rupture of membranes. We assume that the introduction of VA ECMO increased the afterload, decreased the ductal pressure gradient and decreased shunting of blood on the foramen ovale and the ductus arteriosus, resulting in increased pulmonary perfusion which triggered pulmonary hemorrhage in a patient with sepsis and coagulopathy.
Conclusion
In this case report, we have shown that management of severe pulmonary hemorrhage in a newborn on VA ECMO can be achieved by the temporary clamping of the endotracheal tube as a method of last resort if conventional therapeutic options have been exhausted.
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